FENC

Fennec Pharmaceuticals Inc.

Price

$12.72

return (12m)

43.57%

p/e

-128.73

p/bv

9.89

DIVIDEND YIELD

0.00%

FENC price

Fennec Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FENC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.77%

3 months

46.21%

1 year

43.57%

2 years

126.74%

5 years

58.21%

10 years

532.84%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals FENC

Valuation

P/E

-128.73

Sector -4.23

Industry -4.23

P/BV

9.89

Sector 2.11

Industry 2.11

P/Revenue (PSR)

7.09

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

Sector -51.33

Industry -51.33

P/EBIT

Sector -39.56

Industry -39.56

P/Total Assets

5.54

Sector 1.25

Industry 1.25

P/Net Current Assets

10.71

Sector -5.36

Industry -5.36

P/Working Capital

6.98

Sector -1.24

Industry -1.24

EPS

-0.09

Sector -1.92

Industry -1.92

BVPS

1.21

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

93.72%

Sector 39.10%

Industry 39.10%

EBITDA Margin

0.00%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

0.00%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

-1.89%

Sector -36.62%

Industry -36.62%

Net Profit Margins

-5.50%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.24

Sector 0.03

Industry 0.03

Profitability

ROE

-7.68%

Sector -60.49%

Industry -60.49%

ROA

-4.30%

Sector -63.06%

Industry -63.06%

ROIC

0.00%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.85

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.56

Sector 0.43

Industry 0.43

Liabilities/Assets

0.44

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-28.41%

Sector -

Industry -

Fundamentals FENC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FENC Fennec Pharmaceuticals Inc.	$12.72	42.76%	0.00%	-128.73	9.89	-7.68%	-5.50%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FENC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2002

Time since IPO - 24 years

9

Employees

Fennec Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $419.65 million, with shareholders equity totaling $42.44 million.

The company employs approximately 9 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Fennec Pharmaceuticals Inc. reported $59.22 million in revenue, generating net income of $-3.26 million.

Key financial metrics include a P/E ratio of -128.73, a price-to-book (P/B) ratio of 9.89, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FENC.

Market cap

$419.65 million

Net worth

$42.44 million

$42,440,000.00

Assets

$75.75 million

$75,750,000.00

Total Shares Outstanding

35.00 million

35,000,000

Average Daily Trading Volume

$224.39 Thousand

$224,385.06

Sector

Health Care

Industry

Biotechnology

FENC

FENC revenue and profits

Financial Results FENC

DRAG THE FRAME TO SEE MORE DATA

FENC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Fennec Pharmaceuticals (FENC) today?

A cotação de Fennec Pharmaceuticals (FENC) hoje está em US$ 12.72, com uma variação de 43.57% em relação ao último ano. A cotação de Fennec Pharmaceuticals (FENC) iniciou o ano negociando na casa dos US$ 7.70 e hoje está em US$ 12.72. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Fennec Pharmaceuticals (FENC) e dados de ações do Ibovespa e mercados internacionais.

Quando Fennec Pharmaceuticals (FENC) paga dividendos?

Fennec Pharmaceuticals (FENC) não distribuiu dividendos no último ano.

Is Fennec Pharmaceuticals (FENC) a good investment?

Atualmente, Fennec Pharmaceuticals (FENC) está cotada a US$ 12.72, com um P/L de -128.73, representando um desvio de -11,225% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 43.57 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 43.57%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Fennec Pharmaceuticals (FENC) stock?

Investir em ações de Fennec Pharmaceuticals (FENC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Fennec Pharmaceuticals (FENC) yield today?

A rentabilidade de Fennec Pharmaceuticals (FENC) foi de 19.77% no último mês, 43.57% no último ano e 58.21% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Fennec Pharmaceuticals (FENC) hoje, o investimento total seria de US$ 1,272.01, com base na cotação atual de US$ 12.72.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,826.22
Em 5 anos: US$ 2,012.45
Em 10 anos: US$ 8,049.79

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FENC

Fennec Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FENC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING FENC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc.

United States

28 years

2002

9

PROFIT X PRICE FENC

Financial Results FENC

FENC cash flow

Asset, Revenue and Profit Growth - FENC

FENC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions